V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004038 | 290002990 | 1.72 | 60 | Palliative (P) | 2016-03-07 | 2016-04-20 | CAPECITABINE + RT | N | N | 290020453 | PACLITAXEL + TRASTUZUMAB |
| 290004039 | 290002991 | 1.61 | 68.8 | Disease modification (D) | 2013-11-05 | 2013-11-05 | GEMCITABINE | 02 | N | 290020456 | FLUOROURACIL |
| 290004040 | 290002992 | 1.62 | null | Palliative (P) | 2016-11-14 | 2016-11-27 | Capecitabine + Streptozocin | N | N | 290020457 | CAPECITABINE |
| 290004041 | 290002993 | 1.68 | 68.5 | null | 2014-02-02 | 2014-02-02 | Carboplatin + Etoposide iv&po | 2 | N | 290020458 | EOX |
| 290004042 | 290002994 | 1.7 | null | Curative (C) | 2014-12-27 | 2014-12-28 | Capecitabine 35days + RT | 02 | N | 290020459 | CETUXIMAB |
| 290004043 | 290002995 | 1.64 | 62.7 | Curative (C) | 2013-09-29 | 2013-09-29 | MCX | 2 | Y | 290020460 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004044 | 290002996 | 1.64 | 41.4 | Palliative (P) | 2015-11-26 | 2015-11-26 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290020461 | SUNITINIB |
| 290004045 | 290002997 | null | 46.2 | Adjuvant (A) | 2018-01-26 | 2018-01-28 | Hydroxycarbamide | 02 | N | 290020463 | ECX |
| 290004046 | 290006404 | 1.57 | 91 | Adjuvant (A) | 2017-07-27 | 2017-08-14 | EC | N | N | 290020469 | IBRUTINIB |
| 290004047 | 290006404 | 1.63 | 51 | null | 2017-05-14 | 2017-06-02 | OCTREOTIDE | 02 | N | 290020469 | CAPECITABINE + CARBOPLATIN |
| 290004048 | 290002998 | 1.75 | 71 | Curative (C) | 2015-06-23 | 2015-06-23 | Capecitabine + Cisplatin | N | N | 290020472 | CAPECITABINE + CISPLATIN + RT |
| 290004049 | 290002998 | 1.51 | 70.2 | Neo-adjuvant (N) | 2016-11-09 | 2016-11-09 | LANREOTIDE | 02 | N | 290020472 | EOX |
| 290004050 | 290002998 | 1.66 | 57 | Not known (9) | 2016-07-23 | 2016-07-26 | Trial Unspecified | 02 | N | 290020472 | CETUXIMAB |
| 290004051 | 290002999 | 1.6 | 80.5 | null | 2016-10-08 | 2016-10-08 | Cetuximab + Radiotherapy Load | 02 | null | 290020482 | DOXORUBICIN + IFOSFAMIDE |
| 290004052 | 290002999 | 1.59 | null | null | 2018-10-21 | 2018-10-21 | Capecitabine | N | N | 290020482 | BEVACIZUMAB |
| 290004053 | 290003000 | 1.5 | 51.4 | Curative (C) | 2017-06-16 | 2017-06-23 | CAPECITABINE + RT | N | N | 290020484 | CAPECITABINE + RT |
| 290004054 | 290003001 | 1.81 | 83.6 | Curative (C) | 2013-12-05 | 2013-11-25 | Pemetrexed | 02 | N | 290020486 | CAPECITABINE + RT |
| 290004056 | 290003003 | 1.5 | null | Palliative (P) | 2016-04-05 | 2016-04-18 | OCTREOTIDE | N | N | 290020492 | LANREOTIDE |
| 290004057 | 290003004 | 1.64 | 72.2 | Palliative (P) | 2017-01-25 | 2017-01-25 | Bevacizumab 5mg/kg | 2 | N | 290020496 | CISPLATIN + FLUOROURACIL |
| 290004059 | 290003006 | 1.73 | 72.8 | Not known (9) | 2016-06-26 | 2016-07-01 | LANREOTIDE | N | N | 290020500 | CAPECITABINE + RT |
| 290004060 | 290003007 | 0 | null | Adjuvant (A) | 2017-05-01 | 2017-05-01 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | null | N | 290020501 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290004061 | 290003008 | 1.53 | 78.9 | null | 2014-09-19 | 2014-10-20 | Irinotecan + Modified De Gramont | 02 | N | 290020503 | CISPLATIN + GEMCITABINE |
| 290004062 | 290003009 | null | 92.3 | Curative (C) | 2013-09-24 | 2013-10-23 | OCTREOTIDE | 02 | Y | 290020509 | CAPECITABINE + RT |
| 290004063 | 290003010 | 1.85 | 83 | Neo-adjuvant (N) | 2017-05-16 | 2017-05-17 | Cetuximab 7 day (Cycle 1) | N | N | 290020510 | EOX |
| 290004064 | 290003011 | null | null | Neo-adjuvant (N) | 2017-01-19 | 2017-01-28 | ECX | N | N | 290020511 | LANREOTIDE |
| 290004065 | 290003011 | 1.76 | 72 | Curative (C) | 2017-08-20 | 2017-09-03 | CAPECITABINE + RT | N | Y | 290020511 | EOX |
| 290004066 | 290003011 | 1.66 | 72.2 | Disease modification (D) | 2016-09-19 | 2016-09-19 | Capecitabine | N | N | 290020511 | GEMCARBO |
| 290004067 | 290003011 | 1.76 | 52.1 | Palliative (P) | 2014-11-10 | 2014-11-28 | MCX | 02 | N | 290020511 | TRIAL |
| 290004068 | 290003012 | 1.72 | 89 | Palliative (P) | 2015-11-02 | 2015-11-02 | Capecitabine | 02 | N | 290020517 | DACARBAZINE |
| 290004069 | 290003012 | 1.75 | 78.7 | Curative (C) | 2018-01-18 | 2018-02-01 | CAPECITABINE + RT | N | N | 290020517 | CAPECITABINE + RT |
| 290004070 | 290003012 | 1.57 | null | Palliative (P) | 2018-09-09 | 2018-09-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020517 | CARBOPLATIN |
| 290004071 | 290003013 | 1.51 | 69.1 | Adjuvant (A) | 2013-03-08 | 2013-04-09 | Capecitabine 35days + RT | N | Y | 290020525 | CAPECITABINE + RT |
| 290004072 | 290003014 | 1.76 | 73.9 | Neo-adjuvant (N) | 2017-08-30 | 2017-08-30 | DABRAFENIB + TRAMETINIB | 02 | N | 290020526 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN |
| 290004073 | 290003015 | 1.7 | 117 | Palliative (P) | 2014-06-08 | 2014-06-29 | EOX | N | Y | 290020528 | CAPECITABINE |
| 290004074 | 290003016 | 1.8 | 90.6 | Palliative (P) | 2013-10-15 | 2013-10-16 | Capecitabine (14 days)+Carboplatin | N | N | 290020530 | DABRAFENIB + TRAMETINIB |
| 290004075 | 290003017 | 1.66 | null | Neo-adjuvant (N) | 2015-06-01 | 2015-06-08 | Capecitabine (14 day) + Irinotecan | 2 | N | 290020531 | CAPECITABINE + CISPLATIN |
| 290004076 | 290003018 | 1.6 | 115.8 | Curative (C) | null | 2013-10-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020534 | TRASTUZUMAB |
| 290004077 | 290003018 | 1.58 | 72.2 | Palliative (P) | 2015-11-07 | 2015-11-09 | Carboplatin AUC 6 - 10 | 02 | N | 290020534 | CISPLATIN + FLUOROURACIL |
| 290004078 | 290003019 | 1.74 | 57 | Curative (C) | 2017-02-26 | 2017-02-27 | Capecitabine | 02 | N | 290020536 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004079 | 290003020 | 1.45 | 44.1 | null | 2014-11-11 | 2014-11-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 290020538 | CAPECITABINE + TEMOZOLOMIDE |
| 290004080 | 290003021 | null | 65.6 | Palliative (P) | 2017-08-28 | 2017-09-11 | Capecitabine + Cisplatin | N | N | 290020539 | Y-90 |
| 290004081 | 290003021 | 1.78 | 63 | Neo-adjuvant (N) | 2016-12-28 | 2017-01-11 | Gemcitabine + Capecitabine | N | Y | 290020539 | CAPECITABINE + RT |
| 290004082 | 290003021 | 1.68 | 53.5 | Palliative (P) | null | 2018-01-08 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020539 | CISPLATIN + GEMCITABINE |
| 290004083 | 290003022 | 1.81 | 65.2 | Adjuvant (A) | 2014-04-16 | 2014-06-08 | OCTREOTIDE | N | null | 290020542 | OCTREOTIDE |
| 290004084 | 290003023 | 1.8 | 89.5 | Palliative (P) | 2015-09-20 | 2015-10-25 | GEMCITABINE | N | N | 290020544 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004085 | 290003024 | 156 | 101.5 | Palliative (P) | 2015-03-19 | 2015-03-19 | Irinotecan + Modified De Gramont | 02 | N | 290020545 | CARBOPLATIN + PEMETREXED |
| 290004086 | 290003025 | 1.63 | null | Curative (C) | 2016-10-23 | 2016-11-06 | Capecitabine | Y | N | 290020547 | CAPECITABINE |
| 290004087 | 290003025 | 1.66 | 60.4 | Adjuvant (A) | 2014-04-24 | 2014-04-27 | OCTREOTIDE | 02 | null | 290020547 | OCTREOTIDE |
| 290004088 | 290003026 | 1.5 | 65.2 | Curative (C) | 2014-09-24 | 2014-09-30 | Capecitabine + Cisplatin + RT | 2 | Y | 290020550 | FLUOROURACIL |
| 290004089 | 290003027 | 1.79 | 0 | Adjuvant (A) | 2014-07-24 | 2014-08-16 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 290020552 | CARBOPLATIN + RT |